 BEVERLY, Mass., Nov. 16, 2020 GLOBE NEWSWIRE -- LexaGene Holdings, Inc., TSX-V: LXG; OTCQB: LXXGF the Company, a molecular diagnostics company that develops fully automated rapid pathogen detection systems, is pleased to announce that it has received a purchase order for a MiQLabTM system from a multinational biotechnology company that generates billions in annual revenue. 